[1]
World
Health
Organization
(WHO).
Influenza
(Seasonal).
Available
online:
https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) (accessed on 18 March
2020).
[2]
Lam, P.-P.; Coleman, B.L.; Green, K.; Powis, J.; Richardson, D.; Katz, K.; Borgundvaag, B.;
Smith-Gorvie, T.; Kwong, J.C.; Bondy, S.J.; McGeer, A. Predictors of influenza among older
adults in the emergency department. BMC Infect. Dis. 2016, 16, 616–625.
[3]
Gasparini, R.; Bonanni, P.; Amicizia, D.; Bella, A.; Donatelli, I.; Cristina, M.L.; Panatto, D.; Luigi
Lai, P. Influenza epidemiology in Italy two years after the 2009–2010 pandemic need to improve
vaccination coverage. Hum. Vaccin Immunother. 2013, 9, 561–567
[4]
Hale B.G.; Albrecht, R.A.; García-Sastre A. Innate immune evasion strategies of influenza
viruses. Future Microbiol. 2010, 5, 23-41.
[5]
Högner, K.; Wolff, T.; Pleschka, S.; Plog, S.; Gruber, A.D.; Kalinke, U.; Walmrath, H.D.; Bodner,
J.; Gattenlöhner, S.; Lewe-Schlosser, P.; Matrosovich, M.; Seeger, W.; Lohmeyer, J.; Herold, S.
Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe
influenza virus pneumonia. PLoS Pathog. 2013, 9, e1003188.
[6]
Kallfass, C.; Lienenklaus, S,; Weiss, S.; Staeheli, P. Visualizing the beta interferon response in
mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J.
Virol. 2013 87, 6925-30.
[7]
Jewell N.A.; Vaghefi, N.; Mertz, S.E.; Akter, P.; Peebles, R.S.Jr.; Bakaletz, L.O.; Durbin, R.K.;
Flaño, E.; Durbin, J.E. Differential type I interferon induction by respiratory syncytial virus and
influenza a virus in vivo. J. Virol. 2007, 81, 9790–9800.
[8]
Agrawal, P.; Nawadkar, R.; Ojha, H.; Kumar, J.; Sahu, A. Complement evasion strategies of
viruses: An Overview. Front. Microbiol. 2017, 16, 1117.
62
[9]
Villalón-Letelier, F.; Brooks, A.G.; Saunders, P.M.; Londrigan, S.L.; Reading, P.C. Host cell
restriction factors that limit influenza A infection. Viruses 2017, 9, 376.
[10]
Iwasaki A.; Pillai P.S. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 2014, 14,
315-328.
[11]
Takeuchi O.; Akira S. Pattern recognition receptors and inflammation. Cell. 2010, 140, 805–820.
[12]
Le Goffic R.; Pothlichet, J.; Vitour, D.; Fujita, T.; Meurs, E.; Chignard, M.; Si-Tahar, M. Cutting
Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral
responses in human lung epithelial cells. J. Immunol. 2007, 178, 3368–3372.
[13]
Loo, Y.M.; Fornek, J.; Crochet, N.; Bajwa, G.; Perwitasari, O.; Martinez-Sobrido, L.; Akira, S.;
Gill, M.A.; García-Sastre, A.; Katze, M.G.; Gale, M. Jr. Distinct RIG-I and MDA5 signaling by
RNA viruses in innate immunity. J. Virol. 2008, 82, 335-45.
[14]
Kato, H.; Takeuchi. O.; Sato. S.; Yoneyama. M.; Yamamoto. M.; Matsui. K.; Uematsu, S.; Jung,
A.; Kawai, T.; Ishii, K.J.; Yamaguchi, O.; Otsu, K.; Tsujimura, T.; Koh, C.S.; Reis e Sousa, C.;
Matsuura, Y.; Fujita, T.; Akira, S. Differential roles of MDA5 and RIG-I helicases in the
recognition of RNA viruses. Nature 2006,441,101-5.
[15]
Ivashkiv, L.B.; Donlin, L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014,
14, 36–49.
[16]
Krug R.M. Functions of the influenza A virus NS1 protein in antiviral defense. Curr. Opin. Virol.
2015, 12, 1–6.
[17]
Hale B.G.; Randall, R.E.; Ortín, J.; Jackson, D. The multifunctional NS1 protein of influenza A
viruses. J. Gen. Virol. 2008, 89, 2359–2376.
[18]
Gack, M.U.; Albrecht, R.A.; Urano, T.; Inn, K.S.; Huang, I.C.; Carnero, E.; Farzan, M.; Inoue,
S.; Jung, J.U.; García-Sastre, A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to
evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009, 5, 439–449.
63
[19]
Varga, Z.T.; Ramos, I.; Hai, R.; Schmolke, M.; García-Sastre, A.; Fernandez-Sesma, A.; Palese,
P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the
MAVS adaptor protein. PLoS Pathog. 2011, 7, e1002067.
[20]
Graef K.M.; Vreede, F.T.; Lau, Y.F.; McCall, A.W.; Carr, S.M.; Subbarao, K.; Fodor, E. The PB2
subunit of the influenza virus RNA polymerase affects virulence by interacting with the
mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J. Virol.
2010, 84, 8433–8445.
[21]
World Health Organization. Evaluation of influenza vaccine effectiveness: A guide to the design
and
interpretation
of
observational
studies,
2017.
Available
online:
https://apps.who.int/iris/handle/10665/255203 (accessed on 19 September 2020).
[22]
Ujike, M.; Shimabukuro, K.; Mochizuki, K.; Obuchi, M.; Kageyama, T.; Shirakura, M.; Kishida,
N.; Yamashita, K.; Horikawa, H.; Kato, Y.; Fujita, N.; Tashiro, M.; Odagiri, T.; Working Group
for Influenza Virus Surveillance in Japan. Oseltamivir-resistant influenza viruses A (H1N1)
during 2007-2009 influenza seasons, Japan. Emerg. Infect. Dis. 2010, 16, 926–935.
[23]
Takeda, S.; Takeshita, M.; Kikuchi, Y.; Dashnyam, B.; Kawahara, S.; Yoshida, H.; Watanabe, W.;
Muguruma, M.; Kurokawa, M. Efficacy of oral administration of heat-killed probiotics from
Mongolian dairy products against influenza infection in mice: Alleviation of influenza infection
by its immunomodulatory activity through intestinal immunity. Int. Immunopharmacol. 2011, 11,
1976–1983.
[24]
Youn, H.-N.; Lee, D.-H.; Lee, Y.-N.; Park, J.-K.; Yuk, S.-S.; Yang, S.-Y.; Lee, H.-J.; Woo, S.-H.;
Kim, H.-M.; Lee, J-B.; Park, S-Y.; Choi, I-S.; Song, C-S. Intranasal administration of live
Lactobacillus species facilitates protection against influenza virus infection in mice. Antivir. Res.
2012, 93, 138–143.
[25]
Nobuta, Y.; Inoue, T.; Suzuki, S.; Arakawa, C.; Yakabe, T.; Ogawa, M.; Yajima, N. The efficacy
and the safety of Lactobacillus brevis KB290 as a human probiotic. Int. J. Probio. Prebio. 2009,
64
4, 263–270.
[26]
Murakami, K.; Habukawa, C.; Nobuta, Y.; Moriguchi, N.; Takemura, T. The effect of
Lactobacillus brevis KB290 against irritable bowel syndrome: A placebo-controlled double-blind
crossover trial. Biopsychosoc Med. 2012, 6, 16.
[27]
Kishi, A.; Uno, K.; Matsubara, Y.; Okuda, C.; Kishida, T. Effect of the oral administration of
Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J. Am.
Coll. Nutr. 1996, 15, 408–412.
[28]
Fukui, Y.; Sasaki, E.; Fuke, N.; Nakai, Y.; Ishijima, T.; Abe, K.; Yajima, N. Effect of Lactobacillus
brevis KB290 on the cell-mediated cytotoxic activity of mouse splenocytes: A DNA microarray
analysis. Br. J. Nutr. 2013, 110, 1617–29.
[29]
Waki, N.; Yajima, N.; Suganuma, H.; Buddle, B.M.; Luo, D.; Heiser, A.; Zheng, T. Oral
administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following
influenza virus infection. Lett. Appl. Microbiol. 2014, 58, 87–93.
[30]
Waki, N.; Matsumoto, M.; Fukui, Y.; Suganuma, H. Effects of probiotic Lactobacillus brevis
KB290 on incidence of influenza infection among schoolchildren: An open-label pilot study. Lett.
Appl. Microbiol. 2014, 59, 565–571.
[31]
He, R.R.; Wang, M.: Wang, C.Z.; Chen, B.T.; Lu, C.N.; Yao, X.S.; Chen, J.X.; Kurihara, H.
Protective effect of apple polyphenols against stress-provoked influenza viral infection in
restraint mice J. Agric. Food Chem. 2011, 59, 3730-7.
[32]
Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized trial of
vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr.
2010, 91, 1255-60.
[33]
Cser, M.A.; Majchrzak, D.; Rust, P.; Sziklai-László, I.; Kovács, I.; Bocskai, E.; Elmadfa, I. Serum
carotenoid and retinol levels during childhood infections. Ann. Nutr. Metab. 2004, 48, 156-62.
65
[34]
Kandasamy, M.; Suryawanshi, A.; Tundup, S.; Perez, J.T.; Schmolke, M.; Manicassamy, S.;
Manicassamy, B. RIG-I Signaling Is critical for efficient polyfunctional T cell responses during
influenza virus infection. PLoS Pathog. 2016, 12, e1005754.
[35]
Heer, A.K.; Shamshiev, A.; Donda, A.; Uematsu, S.; Akira, S.; Kopf, M.; Marsland, B.J. TLR
signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
J. Immunol. 2007, 178, 2182–91.
[36]
Liu, Y.; Olagnier, D.; Lin, R. Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity.
Front. Immunol. 2017, 7, 662.
[37]
Surman, S.L.; Jones, B.G.; Sealy, R.E.; Rudraraju, R.; Hurwitz, J.L. Oral retinyl palmitate or
retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in
vitamin A deficient mice. Vaccine 2014, 32, 2521–2524.
[38]
Cottey, R.; Rowe, C.A.; Bender, B.S. Influenza virus. Curr. Protoc. Immunol. 2001, 42, Chapter
19, 19.11.1-19. 11. 32.
[39]
Eisfeld, A.J.; Neumann, G.; Kawaoka, Y. Influenza a virus isolation, culture and identification.
Nat. Protoc. 2014, 9, 2663–2681.
[40]
Wood, S.N. Fast stable restricted maximum likelihood and marginal likelihood estimation of
semiparametric generalized linear models. J. R. Stat. Soc. 2011, 73, 3–36.
[41]
Lenth, R.; Buerkner, P.; Herve, M.; Love, J.; Riebl, H.; Singmann, H. Emmeans: Estimated
marginal means, aka least-squares means, R package version 1.4.8; 2020. Available online:
https://CRAN.R-project.org/package=emmeans (accessed on 21 September 2020).
[42]
Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful
approach to multiple testing. J. R. Stat. Soc. 1995, 57, 289–300.
[43]
Drummond, G.B.; Vowler, S.L. Different tests for a difference: How do we do research? J.
Physiol. 2012, 590, 235–238.
66
[44]
Ludbrook, J.; Dudley, H. Why permutation tests are superior to T and F tests in biomedical
research. Am. Stat. 1998, 52, 127–132.
[45]
Maxime, H. RVAideMemoire: Testing and plotting procedures for biostatistics. R package
version 0.9-77; 2020. Available online: https://CRAN.R-project.org/package=RVAideMemoire
(accessed on 21 September 2020).
[46]
Sun, K.; Torres, L.; Metzger, D.W. A detrimental effect of interleukin-10 on protective pulmonary
humoral immunity during primary influenza A virus infection. J. Virol. 2010, 84, 5007–5014.
[47]
Langlois, R.A.; Legge, K.L. Plasmacytoid dendritic cells enhance mortality during lethal
influenza infections by eliminating virus specific CD8 T Cells. J. Immunol. 2010, 184, 4440–
4446.
[48]
Pang, I.K.; Pillai, P.S.; Iwasaki, A. Efficient influenza A virus replication in the respiratory tract
requires signals from TLR7 and RIG-I. Proc. Natl. Acad. Sci. USA 2013, 110, 13910–13915.
[49]
Keef, E.; Zhang, L.A.; Swigon, D.; Urbano, A.; Ermentrout, G.B.; Matuszewski, M.; Toapanta,
F.R.; Ross, T.M.; Parker, R.S.; Clermont, G. Discrete dynamical modeling of influenza virus
infection suggests age-dependent differences in immunity. J. Virol. 2017, 91, e00395–e00417.
[50]
Brandes, M.; Klauschen, F.; Kuchen, S.; Germain, R.N. A systems analysis identifies a
feedforward inflammatory circuit leading to lethal influenza infection. Cell 2013, 154, 197–212.
[51]
Kumova, O.K.; Fike, A.J.; Thayer, J.L.; Nguyen, L.T.; Mell, J.C.; Pascasio, J.; Stairiker, C.; Leon,
L.G.; Katsikis, P.D.; Carey, A.J. Lung transcriptional unresponsiveness and loss of early influenza
virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG. PLoS
Pathog. 2019, 15, e1008072.
[52]
Goto, H.; Sagitani, A.; Ashida, N.; Kato, S.; Hirota, T.; Shinoda, T.; Yamamoto, N. Anti-influenza
virus effects of both live and non-live Lactobacillus acidophilus L-92 accompanied by the
activation of Innate immunity. Br. J. Nutr. 2013, 110, 1810–1818.
67
[53]
Jung, Y.-J.; Lee, Y.-T.; Ngo, V.L.; Cho, Y.-H.; Ko, E.-J.; Hong, S.-M.; Kim, K.-H.; Jang, J.-H.;
Oh, J.-S.; Park, M.-K.; Kim, C-H.; Sun, J.; Kang, S.M. Heat-killed Lactobacillus casei confers
broad protection against influenza A virus primary infection and develops heterosubtypic
immunity against future secondary infection. Sci. Rep. 2017, 7, 17360.
[54]
Nagai, T.; Makino, S.; Ikegami, S.; Itoh, H.; Yamada, H. Effects of oral administration of yogurt
fermented
with
Lactobacillus
delbrueckii
ssp.
bulgaricus
OLL1073R-1
and
its
exopolysaccharides against influenza virus infection in mice. Int. Immunopharmacol. 2011, 11,
2246–2250.
[55]
Kawase, M.; He, F.; Kubota, A.; Yoda, K.; Miyazawa, K.; Hiramatsu, M. Heat-killed
Lactobacillus gasseri TMC0356 protects mice against influenza virus infection by stimulating
gut and respiratory immune responses. FEMS Immunol. Med. Microbiol. 2012, 64, 280–288.
[56]
Nakayama, Y.; Moriya, T.; Sakai, F.; Ikeda, N.; Shiozaki, T.; Hosoya, T.; Nakagawa, H.; Miyazaki,
T. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in
mice. Sci. Rep. 2014, 4, 4638.
[57]
Zelaya, H.; Tada, A.; Vizoso-Pinto, M.G.; Salva, S.; Kanmani, P.; Aguero, G.; Alvarez, S.;
Kitazawa, H.; Villena, J. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates
inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.
Inflamm. Res. 2015, 64, 589–602.
[58]
Park, M.-K.; Ngo, V.; Kwon, Y.-M.; Lee, Y.-T.; Yoo, S.; Cho, Y.-H.; Hong, S.-M.; Hwang, H.S.;
Ko, E.-J.; Jung, Y.-J.; et al. Lactobacillus plantarum DK119 as a probiotic confers protection
against influenza virus by modulating innate immunity. PLoS ONE 2013, 8, e75368.
[59]
Takahashi, E.; Sawabuchi, T.; Kimoto, T.; Sakai, S.; Kido, H. Lactobacillus delbrueckii ssp.
bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by
the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice. J. Dairy Sci.
68
2019, 102, 9559–9569.
[60]
Belkacem, N.; Serafini, N.; Wheeler, R.; Derrien, M.; Boucinha, L.; Couesnon, A.; CerfBensussan, N.; Gomperts Boneca, I.; Di Santo, J.P.; Taha, M.-K.; Bourdet-Sicard, R.
Lactobacillus paracasei feeding improves immune control of influenza infection in mice. PLoS
ONE 2017, 12, e0184976.
[61]
Kiso, M.; Takano, R.; Sakabe, S.; Katsura, H.; Shinya, K.; Uraki, R.; Watanabe, S.; Saito, H.;
Toba, M.; Kohda, N.; Kawaoka, Y. Protective efficacy of orally administered, heat-killed
Lactobacillus pentosus b240 against Influenza A virus. Sci. Rep. 2013, 3, 1563.
[62]
Lee, Y.-N.; Youn, H.-N.; Kwon, J.-H.; Lee, D.-H.; Park, J.-K.; Yuk, S.-S.; Erdene-Ochir, T.-O.;
Kim, K.-T.; Lee, J.-B.; Park, S.-Y.; Choi, I-S.; Song, C.S. Sublingual administration of
Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against
Influenza virus infection in mice. Antivir. Res. 2013, 98, 284–290.
[63]
Sasaki, E.; Suzuki, S.; Fukui, Y.; Yajima, N. Cell-bound exopolysaccharides of Lactobacillus
brevis KB290 enhance cytotoxic activity of mouse splenocytes. J. Appl. Microbiol. 2015, 118,
506–514.
[64]
Matsumiya, T.; Stafforini, D.M. Function and regulation of retinoic acid-inducible gene-I. Crit.
Rev. Immunol. 2010, 30, 489–513.
[65]
Lee, H.; Ko, G. Antiviral effect of vitamin A on norovirus infection via modulation of the gut
microbiome. Sci. Rep. 2016, 6, 25835.
[66]
Pino-Lagos, K.; Guo, Y.; Noelle, R.J. Retinoic acid: A key player in immunity. Biofactors 2010,
36, 430–436.
[67]
Hathcock, J.N.; Hattan, D.G.; Jenkins, M.Y.; McDonald, J.T.; Sundaresan, P.R.; Wilkening, V.L.
Evaluation of vitamin A toxicity. Am. J. Clin. Nutr. 1990, 52, 183–202.
[68]
Gerald, Y.M.; James, K.K.; Wei-Sek, H. Vitamin A hepatotoxicity in multiple family members.
69
Hepatology 1988, 8, 272–275.
[69]
Anroop, B.N.; Shery, J. A simple practice guide for dose conversion between animals and human.
J. Basic Clin. Pharm. 2016, 7, 27–31.
[70]
National
Institute
of
Health
(NIH).
Vitamin
A.
Available
online:
https://ods.od.nih.gov/factsheets/VitaminA-Consumer/ (accessed on 12 October 2022).
[71]
Lobo, G.P.; Hessel, S.; Eichinger, A.; Noy, N.; Moise, A.R.; Wyss, A.; Palczewski, K.; Lintig, J.V.
ISX is a retinoic acid-sensitive gatekeeper that controls intestinal beta, beta-carotene absorption
and vitamin A production. Fed. Am. Soc. Exp. Biol. J. 2010, 24, 1656–1666.
[72]
Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Meyskens, F.L., Jr.; Omenn, G.S.;
Valanis, B.; Williams, J.H., Jr. The beta-carotene and retinol efficacy trial: Incidence of lung
cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene
and retinol supplements. J. Natl. Cancer Inst. 2004, 96, 1743–1750.
[73]
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E
and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J.
Med. 1994, 330, 1029–1035.
[74]
Omenn, G.S.; Goodman, G.; Thornquist, M.; Grizzle, J.; Rosenstock, L.; Barnhart, S.; Balmes,
J.; Cherniack, M.G.; Cullen, M.R.; Glass, A.; Keogh, J.; Meyskens, F. Jr.; Valanis, B.; Williams,
J. Jr. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer
in high risk populations: Smokers and asbestos-exposed workers. Cancer Res. 1994, 54, 2038s–
2043s.
[75]
Kuster, S.P.; Shah, P.S.; Coleman, B.L.; Lam, P.-P.; Tong, A.; Wormsbecker, A.; McGeer, A.
Incidence of influenza in healthy adults and healthcare workers: A systematic review and metaanalysis. PLoS ONE 2011, 6, e26239.
[76]
Sugimura, T.; Takahashi, H.; Jounai, K.; Ohshio, K.; Kanayama, M.; Tazumi, K.; Tanihata, Y.;
Miura, Y.; Fujiwara, D.; Yamamoto, N. Effects of oral intake of plasmacytoid dendritic cells-
70
stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and
immunological response to influenza virus. Br. J. Nutr. 2015, 114, 727–733.
[77]
Sakamoto, H.; Ishikane, M.; Ueda, P. Seasonal influenza activity during the SARS-CoV-2
outbreak in Japan. JAMA 2020, 323, 1969–1971.
[78]
Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.;
et al. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2020, 382,
727–733.
[79]
厚生労働省, Outbreak of Patients with Pneumonia Associated with Coronavirus [1st case], 2020,
Available online: https://www.mhlw.go.jp/stf/newpage_08906.html (accessed on 18 November
2020).
[80]
World Health Organization. 2020. Available online: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/
20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4
(accessed on 18 November 2020).
[81]
厚 生 労 働 省 , Prevention measures against coronavirus disease 2019 (COVID-19). 2020,
Available online: https://www.mhlw.go.jp/content/10900000/000597148.pdf (accessed on 18
November 2020).
[82]
Washing
hands.
2020,
Available
online:
https://www.mhlw.go.jp/content/10900000/000597149.pdf (accessed on 18 November 2020).
[83]
Coughing
manners.
2020,
Available
online:
https://www.mhlw.go.jp/content/10900000/000597150.pdf (accessed on 18 November 2020).
[84]
Deyle, E.R.; Maher, M.C.; Hernandez, R.D.; Basu, S.; Sugihara, G. Global environmental drivers
of influenza. Proc. Natl. Acad. Sci. USA 2016, 113, 13081–13086
[85]
Muto, K.; Yamamoto, I.; Nagasu, M.; Tanaka, M.; Wada, K. Japanese citizens’ behavioral changes
and preparedness against COVID-19: An online survey during the early phase of the pandemic.
71
PLoS ONE 2020, 15, e0234292.
[86]
World
Health
Organization.
2017.
Available
online:
https://www.who.int/influenza/preparedness/pandemic/guidance_
pandemic_influenza_surveillance_2017/en/ (accessed on 21 November 2020).
[87]
Matsumoto, M.; Waki, N.; Suganuma, H.; Takahashi, I.; Kurauchi, S.; Sawada, K.; Tokuda, I.;
Misawa, M.; Ando, M.; Itoh, K.; Ihara, K.; Nakaji, S. Association between biomarkers of
cardiovascular diseases and the blood concentration of carotenoids among the general population
without apparent illness. Nutrients 2020, 12, 2310.
[88]
Minister
of
Health,
Labour
and
Welfare.
2020.
Available
online:
https://www.mhlw.go.jp/content/10900000/000687163.pdf (accessed on 18 June 2021).
[89]
Minister
of
Health,
Labour
and
Welfare.
2020.
Available
online:
https://www.mhlw.go.jp/content/10904750/000586561.pdf (accessed on 29 June 2021).
[90]
Kinoshita, T.; Maruyama, K.; Suyama, K.; Nishijima, M.; Akamatsu, K.; Jogamoto, A.; Katakami,
K.; Saito, I. The effects of OLL1073R-1 yogurt intake on influenza incidence and immunological
markers among women healthcare workers: A randomized controlled trial. Food Funct. 2019, 10,
8129–8136
[91]
Namba, K.; Hatano, M.; Tomoko Yaeshima, T.; Takase, M.; Suzuki, K. Effects of Bifidobacterium
longum BB536 Administration on influenza infection, influenza vaccine antibody titer, and cellmediated immunity in the elderly. Biosci. Biotechnol. Biochem. 2010, 74, 939–945.
[92]
Chew, B.P.; Park, J.S. Carotenoid action on the immune response. J. Nutr. 2004, 134, 257S–261S
[93]
Schindler, M. Theory of synergistic effects: Hill-type response surfaces as ‘null-interaction'
models for mixtures. Theor. Biol. Med. Model. 2017, 14, 15.
[94]
Gudas, L.J. Retinoids and vertebrate development. J. Biol. Chem. 1994, 369, 15399-402.
[95]
McDowell, E.M.; Keenan, K.P.; Huang, M. Effects of vitamin A-deprivation on hamster tracheal
72
epithelium. A quantitative morphologic study. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol.
1984, 45, 197-219.
[96]
McDowell, E.M.; Keenan, K.P.; Huang, M. Restoration of mucociliary tracheal epithelium
following deprivation of vitamin A. A quantitative morphologic study. Virchows Arch. B Cell
Pathol. Incl. Mol. Pathol. 1984, 45, 221-40.
[97]
Koo, J.S.; Jetten, A.M.; Belloni, P.; Yoon, J.H.; Kim, Y.D.; Nettesheim, P. Role of retinoid
receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial
epithelial cells. Biochem J. 1999, 338, 351-7.
[98]
Koo, J.S.; Yoon, J.H.; Gray, T.; Norford, D.; Jetten, A.M.; Nettesheim, P. Restoration of the
mucous phenotype by retinoic acid in retinoid-deficient human bronchial cell cultures: changes
in mucin gene expression. Am. J. Respir. Cell Mol. Biol. 1999, 20, 43-52.
[99]
Stephensen, C.B.; Blount, S.R.; Schoeb, T.R.; Park, J.Y. Vitamin A deficiency impairs some
aspects of the host response to influenza A virus infection in BALB/c mice. J. Nutri. 1993, 125,
823-33.
[100] Zhang, Y.; Lu, Y.; Wang, S.; Yang, L.; Xia, H.; Sun, G. Excessive Vitamin A supplementation
increased the incidence of acute respiratory tract infections: A systematic review and metaanalysis. Nutrients. 2021, 13, 4251.
[101] Stavropoulou, E.; Bezirtzoglou, E. Probiotics in medicine: A long debate. Front. Immunol. 2020,
11, 2192.
[102] Enaud, R.; Prevel, R.; Ciarlo, E.; Beaufils, F.; Wieërs, G.; Guery, B.; Delhaes, L. The gut-lung
axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks. Front.
Cell Infect. Microbiol. 2020, 10, 9.
[103] Trivedi, R.; Barve, K. Gut microbiome a promising target for management of respiratory diseases.
Biochem. J. 2020, 477, 2679-2696.
[104] Zhao, L.; Mao, Y.; Yu, H.; Liu, H.; Wang, C.; Liu, J.; Han, Y.; Bi, Y.; Zhang, D. The preventive
73
effects of Lactobacillus casei on acute lung injury induced by lipopolysaccharide. Indian J.
Microbiol. 2021, 61, 370-382.
74
謝辞
本学位論文をまとめるにあたり、多くのご支援とご指導を賜りました、指導教員である吉田
滋樹 准教授に深く感謝いたします。また、本論文作成にあたり、審査委員として多くのご
助言をいただきました、青柳 秀紀 教授、柏原 真一 准教授、加香 孝一郎 講師には
深く感謝いたします。
インフルエンザ感染モデル試験におきましては、多くのご支援とご指導をいただきました、
AgResearch の Axel Heiser 博士、Sandeep Gupta 博士、Sofia Kanum 博士、Poppy Miller 博士な
らびに同研究機関の皆様に深く感謝いたします。
また、博士後期課程進学前から現在にわたりご指導いただきました、カゴメ株式会社 イノ
ベーション本部
本部長
大行 博士、食健康研究部
上田
宏幸
氏、
健康事業部
シニアスペシャリスト
菅沼
部長 鈴木 重德 博士、 農業資源開発部 課長 井上 拓
郎 氏、食健康研究部 課長 高橋 慎吾 氏に心より感謝申し上げます。
また、本研究を遂行する上でご助言や議論いただいた、カゴメ株式会社 イノベーション本
部 食健康研究部 荒川 千夏 女史、食健康研究部 脇 尚子 博士、そして、食健康研
究部の皆様に厚く御礼申し上げます。
最後に、いつも傍で支えてくれている妻 彩華、そして、好奇心を持ち続けることの大切さ
に気づかせてくれる長女 優衣、長男 勇磨に心から感謝いたします。
75
...
論文の公開元へ
